Hepatitis CNews Articles
New Hepatitis Data Highlight Need for Urgent Global Response
Geneva, Amsterdam?- New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global
Hepatitis EScientific Articles
“Hepatitis E: Urgent Action Needed”
Hepatitis E is increasingly recognised as an important emerging infection in developed countries; however, its heaviest burden rests in Asia and Africa, where disease is endemic and outbreaks are
EV-71News Articles
Genetic Screening to Fight the Common Childhood Virus that Causes Hand, Foot and Mouth Disease
The unavailability of antiviral medicines and vaccines has made outbreaks of hand, food and mouth disease (HFMD) caused by enterovirus 71 (EV71), a serious threat that affects millions worldwide.
HecolinInnovaxScientific Articles
Escherichia Coli-Derived Virus-Like Particles in Vaccine Development
Abstract – Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are
Hepatitis EScientific Articles
A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples
Abstract – Hepatitis E virus (HEV) is transfusion-transmissible and therefore poses a risk to blood transfusion safety. Seroprevalence studies are useful for estimating disease burden and
News ArticlesScientific Articles
In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread
Hand, foot, and mouth disease (HFMD) is a reemerging illness caused by a variety of enteroviruses. The main causative agents are enterovirus 71 (EV71), coxsackievirus A16 (CVA16), and, most
Hepatitis ENews Articles
Médecins Sans Frontières: “The End of Viral Hepatitis by 2030 Is Impossible Without Tackling Hepatitis E”
Soudan Du Sud -?In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis as a public health threat by 2030, focusing primarily on chronic hepatitis B and